Neurofibromatosis, Incorporated, Northeast – Trademark Portfolio
Entity Type: 03
Neurofibromatosis, Incorporated, Northeast holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 1 filings in this category. The portfolio also extends into Class 36 (Insurance & Financial) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include BEAUTY MARK NATION. The owner is based in Burlington, MA.
Burlington, MA 01803
Showing of trademarks Trademarks
Trademark Classifications
Neurofibromatosis, Incorporated, Northeast's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Insurance; financial affairs; monetary affairs; real estate affairs
Frequently Asked Questions
How many trademarks does Neurofibromatosis, Incorporated, Northeast have?
Neurofibromatosis, Incorporated, Northeast has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does Neurofibromatosis, Incorporated, Northeast file in?
Neurofibromatosis, Incorporated, Northeast files trademarks across 2 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 36 (Insurance & Financial). Class 35 covers advertising; business management; business administration; office functions.
What are Neurofibromatosis, Incorporated, Northeast's most well-known trademarks?
Neurofibromatosis, Incorporated, Northeast's registered trademark portfolio includes well-known marks such as BEAUTY MARK NATION. These are among 1 currently registered trademark in the portfolio.
What is Neurofibromatosis, Incorporated, Northeast's trademark registration success rate?
Neurofibromatosis, Incorporated, Northeast has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.